Skip to content

Public FDA record

Z-1854-2020: Esthetic Abutment CC RP 1.5 mm pre-manufactured prosthetic components directly connected to the endosseou

Recall record Z-1854-2020 for Nobel Biocare Usa Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1854-2020
Company in FDA record
Nobel Biocare Usa Llc
FDA record creation date
May 4, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Packages of abutments may contain an incorrect screw. While the screw will tighten, it cannot be guaranteed that the screw will not loosen. In case the screw loosens the abutment should be retightened with the correct screw.

Source facts

Action
Urgent Medical Device Recall Letters were sent to U.S. customers via the U.S Postal Service and OUS customers via email beginning on August 9, 2019. This communication notified customers that the firm had identified a packaging issue affecting six product codes and a total of 7 lots of medical devices (titanium abutments) where the packages of abutment lots may contain an incorrect screw. Customers were informed that while the screw will tighten, it cannot be guaranteed that the screw will not loosen. If the screw loosens, customers are instructed to retighten the abutment with the correct screw. Customers were requested to: i1) identify all devices of the affected lots which they have in stock, 2) not to use the affected devices, 3) complete the Customer Acknowledgement Form and, 4) return it to Nobel Biocare via email at us.complaints@nobelbiocare.com or by fax to 714-282-5073, within 5 days of receipt of the Urgent Medical Device Recall Letter. Customers were instructed to return all devices from affected lots to Nobel Biocare, Attn: Returns PFA1914, 22715 Savi Ranch Parkway, Yorba Linda, CA 92887. The Urgent Medical Device Recall Letter notes that the manufacturer has reviewed the packaging process, has implemented corrective actions and will initiate preventive actions. The letter requests that customers pass the letter on to all those who need to be aware within their organizations or to any organization where the potentially affected devices have been transferred. Customers were instructed to contact their customer support representative at 1-800-322-5001, ext. 1527, if they require further information or support.
Initiated
2019-08-09
Root cause
Process control
Terminated
2021-12-01
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AZ, AR, CA, CO, FL, GA, IL, IN, ID, KS, LA, MI, MD, ME, MA, MO, NY, NC, NJ, NE, NM, OH, OR, OK, PA, TX, TN, VA, WY, WA and WI. Countries of CA, CH, DE, ES, FR, GB, HU, IT, BR, CO, MX, CN, HK, IN, JP and TW.
Recall number
Z-1854-2020
Recall status
Terminated
CDRH record ID
180194
FDA record created
2020-05-04
Recall event number
85159

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗